In a rare move, the companies that make the multiple sclerosis drug daclizumab (brand name Zinbryta) have voluntarily pulled the medication from the market and stopped all clinical studies after reports of eight cases of serious brain inflammation among patients in Europe.
Australia Cans vs Bottles
Crack. Fizz. Gulp. Ahhhhhh. Is there a drinking experience more classically Australian than ripping the ring-pull off a beer? "The visceral pleasure from that first crack of a beer can is identical to popping a champagne cork," says wine and drinks writer Mike Bennie. "There's also huge appeal in the tinnie's nostalgia factor."
0 Comments